14-day Premium Trial Subscription Try For FreeTry Free
One sample Breakout Stocks for Week 10 with better-than-10% short-term upside potential and one sample Dow stock. The MDA Breakout portfolio is up +41.50% YTD c
Wall Street brokerages expect that Epizyme Inc (NASDAQ:EPZM) will announce earnings of ($0.72) per share for the current quarter, according to Zacks. Four analysts have issued estimates for Epizyme’
Epizyme Inc (NASDAQ:EPZM) – Stock analysts at Svb Leerink issued their Q2 2020 earnings per share estimates for Epizyme in a note issued to investors on Monday, February 24th. Svb Leerink analyst A.
Epizyme Inc (NASDAQ:EPZM) – Investment analysts at Wedbush decreased their Q1 2020 earnings per share estimates for shares of Epizyme in a research note issued to investors on Monday, February 24th.
Verrica Pharmaceuticals (NASDAQ:VRCA) and Epizyme (NASDAQ:EPZM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of th
Epizyme Inc (NASDAQ:EPZM) – Svb Leerink issued their Q1 2020 earnings estimates for Epizyme in a report issued on Monday, February 24th. Svb Leerink analyst A. Berens anticipates that the biopharmac
A week ago, Epizyme, Inc. (NASDAQ:EPZM) came out with a strong set of yearly numbers that could potentially lead to a...
Epizyme, Inc. (NASDAQ:EPZM) defied analyst predictions to release its full-year results, which were ahead of market...
First Trust Advisors LP purchased a new stake in shares of Epizyme Inc (NASDAQ:EPZM) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). T
With the coronavirus outbreak spreading rapidly in countries beyond China, so is the fear among investors. Yesterday marked the S&P; 500’s worst one-day performance since February 2018 as the index
With the coronavirus outbreak spreading rapidly in countries beyond China, so is the fear among investors. Yesterday marked the S&P 500’s worst
Epizyme (EPZM) reports wider-than-expected loss in the fourth quarter of 2019. Nonetheless, its sales beat estimates.
Investors need to pay close attention to Epizyme (EPZM) stock based on the movements in the options market lately.
Investors need to pay close attention to Epizyme (EPZM) stock based on the movements in the options market lately.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE